FDA — authorised 14 July 2017
- Application: NDA208379
- Marketing authorisation holder: MEDICURE
- Local brand name: ZYPITAMAG
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 PITAVASTATIN MAGNESIUM in United States
FDA authorised PITAVASTATIN MAGNESIUM on 14 July 2017
Marketing authorisation
PITAVASTATIN MAGNESIUM in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is PITAVASTATIN MAGNESIUM approved in United States?
Yes. FDA authorised it on 14 July 2017.
Who is the marketing authorisation holder for PITAVASTATIN MAGNESIUM in United States?
MEDICURE holds the US marketing authorisation.